Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic ...

A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes ...

The mayor of Rio de Janeiro is promising to make a generic version of Ozempic available through the city’s public health ...

Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...

As online shopping grows and the demand for efficient e-commerce logistics solutions increases, Brussels Airport vows to ...

The Big Pharma company made the move in response to criticism over its high drug costs – in particular, lenacapavir costs $42,250. (STAT) Health startup Roon is raising $15 million from investor ...

Vienna International Airport has now received the CEIV certification for lithium batteries from the International Air ...

A slate of popular policies commonly bandied about to help reduce drug costs would each cut average prices by only a handful of percentage points, according to a recent Congressional Budget Office ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Verona Pharma (VRNA – Research Report), with a price target of $36.00. The company’s shares closed ...

30, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces four oral presentations and two posters on analyses from its successful Phase 3 ...

Piramal Pharma expects new molecule development and an $80 million expansion of its sterile injectable facility in Kentucky to underpin its goal of doubling revenues in the next five years ...